NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2021. “2021 was a miles…
Author: Business Wire
Newport Research Announces Receiving Patent for Novel Cyclosporine Dry Eye Therapy
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Newport Research Announces Receiving Patent for Novel Cyclosporine Dry Eye Therapy
Global Ossicular Reconstruction (ENT Devices) Market Analysis and Forecast Report, 2015-2020 & 2021-2030 Featuring Grace Medical, Heinz Kurz GmbH, Medizintechnik, Medtronic, Olympus Corp – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ossicular Reconstruction (ENT Devices) – Global Market Analysis and Forecast Model” report has been added to ResearchAndMarkets.com’s offering. Ossicular Reconstruction (ENT Devices) – Global Market Analysis and Forecast M…
Présentation des résultats d’une enquête inédite sur l’expérience des personnes dyslexiques portant des lunettes Lexilens®, innovation issue de la startup française ABEYE incubée par Atol les Opticiens
PARIS–(BUSINESS WIRE)–Atol les Opticiens a incubé depuis 2018 la startup française ABEYE qui développe des projets alliant objets connectés (IoT), technologies médicales (MedTech) et intelligence artificielle (IA). Les lunettes électroniques Lexilens…
20th Annual Donate Life Run/Walk Returns to In-Person Event June 4 at Azusa Pacific University
LOS ANGELES–(BUSINESS WIRE)–20th Annual Donate Life Run/Walk Returns to In-Person Event June 4 at Azusa Pacific University
MediPrint™ Ophthalmics Announces Initial Series A Funding Success
SAN DIEGO–(BUSINESS WIRE)–MediPrint™ Ophthalmics Announces Initial Series A Funding Success
$2.06 Billion Opportunities in the Retinal Imaging Devices Global Market up to 2028 – By Device Type and End-User – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Imaging Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Device Type, and End-User” report has been added to ResearchAndMarkets.com’s offering. The retinal imaging devices market is projecte…
Ocular Implants (Glaucoma Implants, Intraocular Lens) Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Implants Market Size, Share & Trends Analysis Report by Product (Glaucoma Implants, Intraocular Lens), by Application (Glaucoma Surgery, Age-related Macular Degeneration), by End Use, by Region, and Segment Fore…
ANJAC Health & Beauty Strengthens Its Presence in North America and Its Pharmaceutical Activities with the Acquisition of Pillar5 Pharma
PARIS–(BUSINESS WIRE)–Today ANJAC Health & Beauty (ANJAC) announced its acquisition of Pillar5 Pharma (Pillar5), one of the primary manufacturers (CDMOs) specializing in the production of sterile ophthalmic solutions and niche solid dose manufact…
RG6501 (OpRegen®) Full Phase 1/2a Results to Be Featured at 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Allen C. Ho, M.D., FACS
CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that full results from a Phase 1/2a …
Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink™ Therapy
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
ANJAC Health & Beauty se renforce en Amérique du Nord et sur ses activités pharmaceutiques en faisant l’acquisition de Pillar5 Pharma
PARIS–(BUSINESS WIRE)–ANJAC Health & Beauty (ANJAC) annonce aujourd’hui l’acquisition de Pillar5 Pharma (Pillar5), l’un des principaux façonniers (CDMO) spécialisés dans la production de solutions ophtalmiques stériles et de formes solides (compr…
Warby Parker Partners With Eastman to Launch New Demo Lens Molecular Recycling Program
NEW YORK–(BUSINESS WIRE)–Warby Parker, the eyewear brand with a mission to inspire and impact the world with vision, purpose, and style, today announced a new partnership with Eastman to pioneer a first-of-its-kind demo lens molecular recycling progr…
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported fi…
Harrow Health Announces Fourth Quarter and Year-End 2021 Financial Results
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced results for the fourth quarter and year ended December 31, 2021. The Company also posted its fourth quarter Lette…
Melt Pharmaceuticals Names Experienced Executive Brad Osborne as Chief Financial Officer
NASHVILLE, Tenn.–(BUSINESS WIRE)–Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing first‑in‑class medicines for sedation and analgesia, today announced the addition of Brad Osborne as Chief Financial Officer. Osborne brin…
Samsara Vision erhält Entgeltvereinbarung NUB Status 1 für SING IMT™
FAR HILLS, N.J.–(BUSINESS WIRE)–Samsara Vision erhält Entgeltvereinbarung NUB Status 1 für SING IMT™
Samsara Vision Awarded NUB Status 1 Reimbursement Designation for SING IMT™
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision Awarded NUB Status 1 Reimbursement Designation for SING IMT™
Global Ophthalmic Lasers Markets (2022 to 2027) – Penetration of the Internet of Things (IoT) in Ophthalmic Laser Care Creates Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers Market Research Report by Type, by Product, by Application, by End-User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. Th…
Théa Completes its Acquisition of Akorn’s Branded Ophthalmic Products Expanding its Presence in the United States Eye Care Industry
LEXINGTON, Mass.–(BUSINESS WIRE)–Théa Pharma Inc. (“Théa”), the US subsidiary of Europe’s leading independent pharmaceutical company specializing in the research, development and commercialization of eye care products, today announced the completion …